Aizawa R, Mizowaki T. Editorial Comment on "Outcomes and Safety Profile of Repeated Progressive
Site-Directed Therapy for Patients With Oligometastatic Castration-Resistant
Prostate Cancer". Int J Urol 2025 Oct 29. doi: 10.1111/iju.70272.
PMID: 41159547
|